Parasitic infection and autoimmunity

Lupus

Volumn 18, Issue 13, 2009, Pages 1144-1148

  Zandman Goddard, G ^a,c   Shoenfeld, Y ^b,c  

^a WOLFSON MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmune diseases; Helminths; Parasites; Protective effect; SLE

Indexed keywords

AUTOANTIBODY; TOLL LIKE RECEPTOR;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HELMINTH; HELMINTHIASIS; HUMAN; IMMUNOMODULATION; MOLECULAR INTERACTION; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRAVIOLET RADIATION;

ANIMALS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HELMINTHS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PARASITIC DISEASES;

EID: 71049151951     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309345735     Document Type: Review

References (33)

1. Sherer Y., Gorstein A., Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004; 34: 501-537.
2. Shoenfeld Y., Zandman-Goddard G., Stojanovich L., et al. The mosaic of autoimmunity: Hormonal and environmental factors involved in autoimmune diseases - 2008. Israel Med Assoc J 2008; 10:8-12.
3. Zandman-Goddard G., Shoenfeld Y. Infections and SLE. Autoimmunity 2005; 38: 473-485.
4. Zandman-Goddard G., Berkun Y., Barzilai O., et al. Exposure to Epstein-Barr virus infection is associated with mild SLE disease. Ann NY Acad Sci 2009; in press.
5. Zandman-Goddard G., Berkun Y., Barzilai O., et al. Neuropsychiatric lupus and infectious triggers. Lupus 2008; 17: 380-384.
6. Ram M., Shoenfeld Y. Hepatitis B: Infection, vaccination and hepatitis B surface antigen. IMAJ 2008; 10: 61-64.
7. van Riet E., Hartgers FC, Yazdanbakhsh M. Chronic helminth infections induce immunomodulation: Consequences and mechanisms. Immunobiology 2007; 212: 475-490.
8. Finkelman FD, Shea-Donohue T., Morris SC, et al. Interleukin-4 and interleukin 13-mediated host protection against intestinal nematode parasites. Immunol Rev 2004; 201: 139-155.
9. Cervi L., MacDonald AS, Kane C., Dzierszinki F., Pearce EJ Cutting edge: dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. J Immunol 2004; 172: 2016-2020.
10. Balic A., Harcus Y., Hooland MJ, Maizels RM Selective maturation of dendritic cells by Nippostrogylus brasiliensis-secreted proteins drives Th2 immune responses. Eur J Immunol 2004; 34: 3047-3059.
11. Thomas PG, Carter MR, Atochina O., et al. Maturation of dendritic cell 2 phenotype by a helminth glycan uses a toll-like receptor 4-dependent mechanism. J Immunol 2003; 171: 5837-5841.
12. Whelan M., Harnett MM, Houston KM, Patel V., Harnett W., Rigley KP A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J Immunol 2000; 164: 6453-6460.
13. Kane CM, Cervi L., Sun J., et al. Helminth antigens modulate TLRinitiated dendritic cell activation. J Immunol 2004; 173: 7454-7461.
14. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
15. van der Kleij D., Latz E., Brouwers JF, et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates Toll-like receptor 2 and affects immune polarization. J Biol Chem 2002; 277: 48122-48129.
16. Askoy E., Zouain CS, Vanhoutte F., et al. Double stranded RNAs from the helminth parasite Schistosoma activate TLR3 in dendritic cells. J Biol Chem 2005; 280: 277-283.
17. Goodridge HS, Marshall FA, Else KJ, et al. Immunomodulation via novel use of TLR4 by the filarial nematode phosporylcholinecontaining secreted product, ES-62. J Immunol 2005; 174: 284-293.
18. Abu-Shakra M., Shoenfeld Y. Parasitic infection and autoimmunity. In: Shoenfeld Y, Rose N (eds), Infection and autoimmunity. Amsterdam: Elsevier; 2004. p. 439-448.
19. Zandman-Goddard G., Chapman J., Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum 2007; 36: 297-315.
20. Levitus G., Hontebeyrie-Joskowicz M., Van-Regenmortel MH, Levin MJ Humoral autoimmune response to ribosomal P proteins in demonstrated in chronic Chagas heart disease. Clin Exp Immunol 1991; 85: 413-417.
21. Perone D., santos MA, Peixoto MS, Cicarelli RM Trypanosoma cruzi: identification and characterization of a novel ribosomal protein L27 (TcrL27) that cross-reacts with an affinity-purified anti-Sm antibody. Parasitology 2003; 126: 577-583.
22. Cooke A., Tonks P., Jones FM, et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol 1999; 21: 169-176.
23. Zaccone P., Fehervari Z., Jones FM, et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type I diabetes. Eur J Immunol 2003;33: 1439-1449.
24. Moreels TG, Nieuwendijk RJ, De Man JG, et al. Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats. Gut 2004; 53: 99-107.
25. Khan WI, Blennerhasset PA, Varghese AK, et al. Intestinal nematode infection ameliorates experimental colitis in mice. Infect Immunol 2002; 70: 5931-5937.
26. Summers RW, Elliot DE, Urban JF Jr, Thompson RA, Weinstock JV Trichuris suis therapy for active ulcerative colitis: A randomized controlled trial. Gastroenterology 2005; 128: 825-832.
27. Sewell D., Qing Z., Reinke E., et al. Immunomodulation of experimental allergic encephalitis by helminth ova immunization. Int Immunol 2003; 15: 59-69.
28. Diaz A., Allen JE Mapping immune response profiles: The emerging scenario from helminth immunology. Eur J Immunol 2007; 37: 3319-3326.
29. Hyland KV, Leon JS, Daniels MD, et al. Modulation of autoimmunity by treatment of an infectious disease. Infection Immun 2007; 75: 3641-3650.
30. La Flamme AC, Ruddenklau K., Backstrom BT Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalitis. Infect Immun 2003; 71: 4996-5004.
31. Berkun Y., Zandman-Goddard G., Barzilai O., et al. Infectious antibodies in systemic lupus erythematosus patients. Lupus 2009; this issue.
32. Chen M., Aosai F., Norose K., et al. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand black X New Zealand white) F1 mice. Int Immunol 2004; 16: 937-946.
33. Clatworthy MR, Willcocks L., Urban B., et al. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Proc Natl Acad Sci USA 2007; 104: 7169-7174.